戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ular and clinical phenotype of patients with epidermolysis bullosa.
2 on seen in patients with dystrophic forms of epidermolysis bullosa.
3  skin blistering disorder Herlitz junctional epidermolysis bullosa.
4 o the chronic blistering disease, dystrophic epidermolysis bullosa.
5 ntified as the candidate gene for dystrophic epidermolysis bullosa.
6 tended family members at risk for junctional epidermolysis bullosa.
7 e to the blistering skin disease, dystrophic epidermolysis bullosa.
8 l junction, diagnostic of Herlitz junctional epidermolysis bullosa.
9 nts with the recessive dystrophic subtype of epidermolysis bullosa.
10 ocyte integrity and resilience in junctional epidermolysis bullosa.
11 idesmosomes was also perturbed in junctional epidermolysis bullosa.
12 c with other variants of dominant dystrophic epidermolysis bullosa.
13  occurs in some blistering disorders such as epidermolysis bullosa.
14 idermolysis bullosa, and dystrophic forms of epidermolysis bullosa.
15 in for mutations in some forms of junctional epidermolysis bullosa.
16 is a clinical variant of dominant dystrophic epidermolysis bullosa.
17 en gene (COL7A1) in patients with dystrophic epidermolysis bullosa.
18 tic syndrome, interstitial lung disease, and epidermolysis bullosa.
19 d bone marrow transplantation for dystrophic epidermolysis bullosa.
20 f gene therapy for junctional and dystrophic epidermolysis bullosa.
21 in of two patients with recessive dystrophic epidermolysis bullosa.
22 ative medicine to cutaneous diseases such as epidermolysis bullosa.
23 umours of patients with Recessive Dystrophic Epidermolysis Bullosa, a disease characterized by chroni
24 an pedigree with generalized atrophic benign epidermolysis bullosa, a distinct nonlethal form of junc
25                Severe generalized junctional epidermolysis bullosa, a lethal hereditary blistering di
26    Patients with generalized atrophic benign epidermolysis bullosa, a usually nonlethal form of junct
27                                              Epidermolysis bullosa acquisita (EBA) is a chronic mucoc
28                                              Epidermolysis bullosa acquisita (EBA) is a prototypic or
29                                              Epidermolysis bullosa acquisita (EBA) is a rare blisteri
30                                              Epidermolysis bullosa acquisita (EBA) is an acquired bli
31                                              Epidermolysis bullosa acquisita (EBA) is an acquired bul
32                                              Epidermolysis bullosa acquisita (EBA) is an AIBD associa
33                                              Epidermolysis bullosa acquisita (EBA) is an autoimmune b
34                                              Epidermolysis bullosa acquisita (EBA) is an autoimmune b
35                                              Epidermolysis bullosa acquisita (EBA) is an autoimmune b
36                                              Epidermolysis bullosa acquisita (EBA) is an autoimmune s
37 d against tissue destruction in experimental epidermolysis bullosa acquisita (EBA), an AIBD caused by
38 flammation, we employed immunization-induced epidermolysis bullosa acquisita (EBA), an autoimmune bul
39                                           In epidermolysis bullosa acquisita (EBA), an autoimmune dis
40  mice that mimic those seen in patients with epidermolysis bullosa acquisita (see the related article
41 evelopment of new therapeutic strategies for epidermolysis bullosa acquisita and related autoimmune d
42                                              Epidermolysis bullosa acquisita autoantibodies bound to
43 ought to determine if type VII collagen, the epidermolysis bullosa acquisita autoantigen, was present
44 ction crystallizable glycosylation in murine epidermolysis bullosa acquisita in congenic mouse strain
45                                              Epidermolysis bullosa acquisita is a subepidermal bliste
46                                              Epidermolysis bullosa acquisita is an autoimmune blister
47                                              Epidermolysis bullosa acquisita is an autoimmune skin-bl
48                                              Epidermolysis bullosa acquisita is caused by antibodies
49 immunofluorescence microscopy, not diagnosed epidermolysis bullosa acquisita or anti-laminin-332 muco
50             Furthermore, autoantibodies from epidermolysis bullosa acquisita patients also reacted wi
51                                  IgG from an epidermolysis bullosa acquisita serum containing autoant
52 -145, were applied to mice with experimental epidermolysis bullosa acquisita, an autoimmune bullous d
53  Systemic diseases are often associated with epidermolysis bullosa acquisita, Crohn's disease being t
54 igus vulgaris/foliaceus, bullous pemphigoid, epidermolysis bullosa acquisita, mucous membrane pemphig
55 action may contribute to the pathogenesis of epidermolysis bullosa acquisita.
56 tise and classified as bullous pemphigoid or epidermolysis bullosa acquisita.
57 e skin of children with recessive dystrophic epidermolysis bullosa after allogeneic bone marrow trans
58 ing the role of alpha 6 beta 4 in junctional epidermolysis bullosa, an often lethal human disorder wi
59 pulation carrier risk for Herlitz junctional epidermolysis bullosa and all variants of junctional epi
60 COL7A1 mutations in patients with dystrophic epidermolysis bullosa and compared them with an establis
61   To explain the milder recessive dystrophic epidermolysis bullosa and junctional epidermolysis bullo
62 f hemophilia, tyrosinemia type I, junctional epidermolysis bullosa and type 1 diabetes.
63 n a patient with generalized atrophic benign epidermolysis bullosa, and applies a new methodology to
64 is, similar to that seen in human junctional epidermolysis bullosa, and death occurs within a few day
65 molytic palmoplantar keratoderma, junctional epidermolysis bullosa, and dystrophic forms of epidermol
66 ants causing AI in the absence of junctional epidermolysis bullosa, and highlights the shared AI phen
67 helming majority of patients with dystrophic epidermolysis bullosa, and most of them in this Iranian
68 e prototypic heritable blistering disorders, epidermolysis bullosa, and related keratinopathies, in w
69 ies underlying different forms of junctional epidermolysis bullosa appear to affect certain critical
70 riasis, infantile hemangiomas and dystrophic epidermolysis bullosa are reviewed.
71 sive cSCCs (n = 71) and recessive dystrophic epidermolysis bullosa-associated cSCCs (n = 11) than in
72  patients with severe generalized junctional epidermolysis bullosa born in the years 2000-2015.
73 s did not have the lethal form of junctional epidermolysis bullosa but, as adults, displayed the mild
74  there is no effective treatment or cure for epidermolysis bullosa, but bone marrow transplantation h
75   Treatment of severe generalized junctional epidermolysis bullosa by SCT is a last-ditch attempt sti
76  cells of patients with recessive dystrophic epidermolysis bullosa can be corrected by homology-direc
77 ibrils in patients with recessive dystrophic epidermolysis bullosa can be morphologically altered, re
78  one in 350, respectively, while the overall epidermolysis bullosa carrier frequency was calculated t
79 ement or cell-based therapies for dystrophic epidermolysis bullosa caused by genetic deficiency of co
80 study was performed from 2003 to 2023 at the Epidermolysis Bullosa Centre, University of Freiburg, Ge
81 variants in LAMB3 cause recessive junctional epidermolysis bullosa, characterized by life-threatening
82 EB) and recessive (RDEB) forms of dystrophic epidermolysis bullosa (DEB) and have subsequently identi
83                      The dystrophic forms of epidermolysis bullosa (DEB) are characterized by fragili
84                      The dystrophic forms of epidermolysis bullosa (DEB) are due to mutations in the
85                                   Dystrophic epidermolysis bullosa (DEB) is a blistering skin disease
86                                   Dystrophic epidermolysis bullosa (DEB) is a family of inherited mec
87                                   Dystrophic epidermolysis bullosa (DEB) is a family of inherited mec
88                                   Dystrophic epidermolysis bullosa (DEB) is an inherited mechano-bull
89                                   Dystrophic epidermolysis bullosa (DEB) is an inherited mechano-bull
90                                   Dystrophic epidermolysis bullosa (DEB) is an inherited mechanobullo
91                                   Dystrophic epidermolysis bullosa (DEB) is due to mutations in the t
92 gene COL7A1 encoding for C7 cause dystrophic epidermolysis bullosa (DEB), a genetic mechano-bullous d
93 to underlie different variants of dystrophic epidermolysis bullosa (DEB).
94 L7A1) have been shown to underlie dystrophic epidermolysis bullosa (DEB).
95 inherited blistering skin disease dystrophic epidermolysis bullosa (DEB).
96 teeth from patients suffering from recessive epidermolysis bullosa dystrophica (rEBD) in terms of its
97                           Heritable forms of epidermolysis bullosa (EB) are characterized by chronic,
98                                Patients with epidermolysis bullosa (EB) do not carry a significantly
99                                              Epidermolysis bullosa (EB) is a class of intractable, ra
100                                              Epidermolysis bullosa (EB) is a clinically and genetical
101                                              Epidermolysis bullosa (EB) is a group of autosomal domin
102                                              Epidermolysis bullosa (EB) is a group of genetic disorde
103                                              Epidermolysis bullosa (EB) is a group of mechanobullous
104                                              Epidermolysis bullosa (EB) is a group of rare genetic di
105                                              Epidermolysis bullosa (EB) is an inherited, heterogeneou
106                                   Hereditary epidermolysis bullosa (EB) is associated with skin blist
107  incidence and prevalence of each subtype of epidermolysis bullosa (EB) is essential before clinical
108 anel of well-characterized plasma samples of epidermolysis bullosa (EB) patients suffering from (chro
109                                              Epidermolysis bullosa (EB) pruriginosa is a rare variant
110                                              Epidermolysis bullosa (EB) simplex is a rare genetic con
111                                              Epidermolysis bullosa (EB) with late-onset muscular dyst
112                                              Epidermolysis bullosa (EB), a group of complex heritable
113                       The heritable forms of epidermolysis bullosa (EB), a phenotypically heterogeneo
114 s with the inherited skin-blistering disease epidermolysis bullosa (EB), we show that large numbers o
115  caries experience in the different types of epidermolysis bullosa (EB).
116 ases with epidermal loss, such as junctional epidermolysis bullosa (EB).
117 In a distinct autosomal recessive variant of epidermolysis bullosa, EB-MD, life-long skin blistering
118  gene for mutations in 22 Herlitz junctional epidermolysis bullosa families, and identified 15 distin
119 ne responses that may arise in patients with epidermolysis bullosa following BPAG2 gene replacement,
120                  Generalized atrophic benign epidermolysis bullosa (GABEB) is a nonlethal variant of
121                  Generalized atrophic benign epidermolysis bullosa, GABEB (OMIM# 226650), is a nonlet
122 rous sclerosis complex, and several forms of epidermolysis bullosa, genetic research has resulted in
123               The Herlitz type of junctional epidermolysis bullosa (H-JEB) is a severe blistering dis
124 the skin of patients with Herlitz junctional epidermolysis bullosa (H-JEB).
125 r systemic sclerosis or recessive dystrophic epidermolysis bullosa has led to the common finding of s
126 losa, a usually nonlethal form of junctional epidermolysis bullosa, have generalized blistering, nail
127 sease Hallopeau-Siemens recessive dystrophic epidermolysis bullosa (HS-RDEB) results from mutations i
128 g the manifestations of recessive dystrophic epidermolysis bullosa in humans.
129         The clinical phenotype of junctional epidermolysis bullosa in the proband in this family prob
130 hese results suggest that Herlitz junctional epidermolysis bullosa in this patient developed as a res
131 y in generalised severe recessive dystrophic epidermolysis bullosa, in which blood and marrow transpl
132 e cases of the nonlethal forms of junctional epidermolysis bullosa involving abnormalities in laminin
133 e cases of the nonlethal forms of junctional epidermolysis bullosa involving abnormalities in laminin
134                         Recessive dystrophic epidermolysis bullosa is a devastating blistering diseas
135                                              Epidermolysis bullosa is a family of diseases characteri
136                                   Junctional epidermolysis bullosa is a group of hereditary bullous d
137                                              Epidermolysis bullosa is a group of heritable skin fragi
138                           Herlitz junctional epidermolysis bullosa is a heritable bullous disease cau
139                                   Dystrophic epidermolysis bullosa is a heritable skin disease manife
140                                   Junctional epidermolysis bullosa is a heterogeneous autosomal reces
141                                              Epidermolysis bullosa is a heterogeneous group of herita
142                                   Dystrophic epidermolysis bullosa is a rare genetic blistering skin
143                                   Dystrophic epidermolysis bullosa is a rare genetic disease caused b
144                                   Dystrophic epidermolysis bullosa is a rare genetic skin disorder ca
145                  Generalized atrophic benign epidermolysis bullosa is an autosomal recessive subepide
146                         Recessive dystrophic epidermolysis bullosa is an incurable, often fatal mucoc
147                                              Epidermolysis bullosa is caused by mutations in at least
148 inherited mechanobullous disease, dystrophic epidermolysis bullosa, is caused by type VII collagen ge
149                          Junctional forms of epidermolysis bullosa (JEB) are associated with mutation
150                                   Junctional epidermolysis bullosa (JEB) is a heterogeneous group of
151                                   Junctional epidermolysis bullosa (JEB) is an autosomal recessive di
152                                   Junctional epidermolysis bullosa (JEB) is an autosomal recessive sk
153                                   Junctional epidermolysis bullosa (JEB) is an inherited mechanobullo
154   The blistering disorder, lethal junctional epidermolysis bullosa (JEB), can result from mutations i
155 (GABEB) is a nonlethal variant of junctional epidermolysis bullosa (JEB).
156                        In Herlitz junctional epidermolysis bullosa (laminin 5 abnormalities, n = 4) t
157  total number of distinct Herlitz junctional epidermolysis bullosa mutations in LAMB3 to 35.
158  patients with different forms of junctional epidermolysis bullosa (n = 13).
159  = 3) or with autosomal recessive dystrophic epidermolysis bullosa (n = 4) were included as controls.
160  1 of 150,000, severe generalized junctional epidermolysis bullosa occurred more often than published
161    Patients with generalized atrophic benign epidermolysis bullosa often show decreased expression of
162 BP), and absent in patients with one type of epidermolysis bullosa (OMIM #226650).
163                           Herlitz junctional epidermolysis bullosa (OMIM#226700) is a lethal, autosom
164 ic DNA predicted severe recessive dystrophic epidermolysis bullosa or junctional epidermolysis bullos
165 cessive blistering skin disorder, junctional epidermolysis bullosa, particularly in the lethal (Herli
166             Advances in our understanding of epidermolysis bullosa pathophysiology have provided the
167                     The recessive dystrophic epidermolysis bullosa patients had a homozygous single b
168 gh caries experience in recessive dystrophic epidermolysis bullosa patients is probably related to ot
169 he cDNA were detected, and in the junctional epidermolysis bullosa patients transcripts with in-frame
170                               The junctional epidermolysis bullosa patients were compound heterozygot
171 ee techniques we have screened 93 dystrophic epidermolysis bullosa patients yielding an overall sensi
172             Findings in recessive dystrophic epidermolysis bullosa patients' skin were indistinguisha
173                  In the recessive dystrophic epidermolysis bullosa patients, transcripts containing i
174 otal of 50 dominant and recessive dystrophic epidermolysis bullosa patients.
175 strophic epidermolysis bullosa or junctional epidermolysis bullosa phenotypes but in whom the manifes
176 trophic epidermolysis bullosa and junctional epidermolysis bullosa phenotypes in these families, reve
177                                          New epidermolysis bullosa phenotypes, genotypes and modes of
178            A total of 270 of the ~320 COL7A1 epidermolysis bullosa PNVs reside in exons that can be s
179 ts with the distinctive clinical features of epidermolysis bullosa pruriginosa is heterogeneous and s
180 OL7A1 mutation(s), may be responsible for an epidermolysis bullosa pruriginosa phenotype.
181 a distinct clinical subtype of this disease, epidermolysis bullosa pruriginosa, characterized by prur
182 ytes from patients with recessive dystrophic epidermolysis bullosa (RDEB) and normal dermal fibroblas
183 skin blistering disease recessive dystrophic epidermolysis bullosa (RDEB) develop aggressive cutaneou
184                         Recessive dystrophic epidermolysis bullosa (RDEB) is a complex inherited skin
185                         Recessive dystrophic epidermolysis bullosa (RDEB) is a debilitating genoderma
186             Importance: Recessive dystrophic epidermolysis bullosa (RDEB) is a devastating, often fat
187             The recessive dystrophic form of epidermolysis bullosa (RDEB) is a disorder of incurable
188                         Recessive dystrophic epidermolysis bullosa (RDEB) is a genetic skin fragility
189                         Recessive dystrophic epidermolysis bullosa (RDEB) is a rare condition in whic
190                         Recessive dystrophic epidermolysis bullosa (RDEB) is a rare monogenic blister
191                         Recessive dystrophic epidermolysis bullosa (RDEB) is a severe inherited skin-
192                         Recessive dystrophic epidermolysis bullosa (RDEB) is an autosomal recessive d
193                         Recessive dystrophic epidermolysis bullosa (RDEB) is an incurable disease cau
194                         Recessive dystrophic epidermolysis bullosa (RDEB) is an inherited blistering
195                         Recessive dystrophic epidermolysis bullosa (RDEB) is an inherited disorder ch
196                         Recessive dystrophic epidermolysis bullosa (RDEB) is caused by defects of typ
197                         Recessive dystrophic epidermolysis bullosa (RDEB) is caused by defects of typ
198 ted in vivo utilizing a recessive dystrophic epidermolysis bullosa (RDEB) knockout mouse model.
199 t that individuals with recessive dystrophic epidermolysis bullosa (RDEB) only develop squamous-cell
200 agility disorder coined recessive dystrophic epidermolysis bullosa (RDEB) that is associated with a c
201 plored their utility in recessive dystrophic epidermolysis bullosa (RDEB), a blistering disease due t
202  collagen defects cause recessive dystrophic epidermolysis bullosa (RDEB), a blistering skin disorder
203 s of severe generalized recessive dystrophic epidermolysis bullosa (RDEB), a currently incurable blis
204        Individuals with recessive dystrophic epidermolysis bullosa (RDEB), a rare genetic skin diseas
205 currently available for recessive dystrophic epidermolysis bullosa (RDEB), a severe heritable blister
206 listering skin disorder recessive dystrophic epidermolysis bullosa (RDEB), caused by mutations in the
207 blistering skin disease recessive dystrophic epidermolysis bullosa (RDEB), which is characterized by
208 in patients affected by recessive dystrophic epidermolysis bullosa (RDEB).
209 ting blistering disease recessive dystrophic epidermolysis bullosa (RDEB).
210 ion in individuals with recessive dystrophic epidermolysis bullosa (RDEB).
211 unrelated families with recessive dystrophic epidermolysis bullosa (RDEB).
212 rm of the skin blistering disease dystrophic epidermolysis bullosa (RDEB).
213 ients consecutively enrolled in the National Epidermolysis Bullosa Registry from January 1, 1986, thr
214 nomic evaluation used data from the National Epidermolysis Bullosa Registry to estimate the current p
215  forms of recessive dystrophic or junctional epidermolysis bullosa, respectively.
216 yses have revealed that recessive dystrophic epidermolysis bullosa results from mutations in the type
217 ng the complete set of genes associated with epidermolysis bullosa revealed a homozygous nonsense mut
218              Through studies that began with epidermolysis bullosa simplex (EBS) and now extend to a
219                                              Epidermolysis bullosa simplex (EBS) is a group of autoso
220                                  Importance: Epidermolysis bullosa simplex (EBS) is a group of clinic
221                                              Epidermolysis bullosa simplex (EBS) is a mechano-bullous
222                                              Epidermolysis bullosa simplex (EBS) is a rare genetic co
223                                              Epidermolysis bullosa simplex (EBS) is a rare inherited
224                                              Epidermolysis bullosa simplex (EBS) is a severe and pote
225                                              Epidermolysis bullosa simplex (EBS) is an incurable, inh
226                                              Epidermolysis bullosa simplex (EBS) is an inherited skin
227                                              Epidermolysis bullosa simplex (EBS) refers to a heteroge
228                 The blistering skin disorder epidermolysis bullosa simplex (EBS) results from dominan
229           Mutations in K5 or K14 genes cause epidermolysis bullosa simplex (EBS), a disorder with bli
230  The best-studied skin fragility disorder is epidermolysis bullosa simplex (EBS), an autosomal domina
231                          One such disease is epidermolysis bullosa simplex (EBS), caused by mutations
232 ins keratin 5 (K5) or keratin 14 (K14) cause epidermolysis bullosa simplex (EBS), in which basal laye
233  junctions (NMJs) in patients suffering from epidermolysis bullosa simplex (EBS)-muscular dystrophy (
234 ns 5 or 14 are implicated in the etiology of epidermolysis bullosa simplex (EBS).
235                 The Dowling-Meara variant of epidermolysis bullosa simplex (EBS-DM) is a severe blist
236 athy type VI (caused by a loss of DST-a) and Epidermolysis bullosa simplex 3 (caused by a loss of DST
237 d in skin lead to human disorders, including epidermolysis bullosa simplex and epidermolytic hyperker
238                                              Epidermolysis bullosa simplex are dominant disorders of
239                                              Epidermolysis bullosa simplex associated with late-onset
240                                           In epidermolysis bullosa simplex associated with plectin mu
241                                              Epidermolysis bullosa simplex Dowling-Meara (MIM# 131760
242 dy we sequenced these genes in a family with epidermolysis bullosa simplex Dowling-Meara.
243 e K5 head domain residue T150 in cytoplasmic epidermolysis bullosa simplex granules containing R125C
244             The severe Dowling-Meara form of epidermolysis bullosa simplex is caused by dominant-nega
245 istic feature of the skin blistering disease epidermolysis bullosa simplex is keratin filament (KF) n
246 rmation and function with a possible role in epidermolysis bullosa simplex pathogenesis.
247                           This is the second epidermolysis bullosa simplex patient reported with a pr
248                                 We report an epidermolysis bullosa simplex patient with a novel singl
249                                 Mutations in epidermolysis bullosa simplex patients could interfere w
250 common mutation in the Dowling-Meara form of epidermolysis bullosa simplex patients is the missense m
251 models that more faithfully recapitulate the epidermolysis bullosa simplex phenotype, is advisable be
252  the palmoplantar distribution seen in other epidermolysis bullosa simplex subtypes, extensive herpet
253 7600) is the most severe of the three common epidermolysis bullosa simplex subtypes.
254 plantation could be applied to patients with epidermolysis bullosa simplex with intraepidermal bliste
255 utation P25L in the V1 domain of keratin 5), epidermolysis bullosa simplex with migratory circinate e
256 everal distinct clinical phenotypes, such as epidermolysis bullosa simplex with mottled pigmentation
257                                              Epidermolysis bullosa simplex with muscular dystrophy (E
258 ents suffering from plectinopathy-associated epidermolysis bullosa simplex with muscular dystrophy (E
259  skin from patients with autosomal recessive epidermolysis bullosa simplex with plectin defects (n =
260 r dystrophy associated with skin blistering (epidermolysis bullosa simplex).
261 ing disorders, epidermolytic hyperkeratosis, epidermolysis bullosa simplex, epidermolytic palmoplanta
262          To date, mutant-specific siRNAs for epidermolysis bullosa simplex, pachyonychia congenita an
263 cal vitelliform macular dystrophy (VMD1) and epidermolysis bullosa simplex, type Ogna (EBS1).
264 e motif have been described in patients with epidermolysis bullosa simplex.
265 vidence of phenotype-genotype correlation in epidermolysis bullosa simplex.
266 mutations in either of these genes can cause epidermolysis bullosa simplex.
267 g seen in the genetic disorder Dowling-Meara epidermolysis bullosa simplex.
268 al trials of bone marrow transplantation for epidermolysis bullosa simplex.
269 s in EXPH5 in an autosomal recessive form of epidermolysis bullosa simplex.
270 eness of squamous cell carcinomas arising in epidermolysis bullosa skin.
271 s the limitations in predicting phenotype in epidermolysis bullosa solely based on mutation analysis
272 cutaneous complications in each of the major epidermolysis bullosa subtypes.
273  of COL17A1 disease from autosomal recessive epidermolysis bullosa to autosomal dominant ERED and ide
274  patients with severe generalized junctional epidermolysis bullosa treated with allogeneic stem cell
275  patients with nonlethal forms of junctional epidermolysis bullosa using polymerase chain reaction am
276  patients with nonlethal forms of junctional epidermolysis bullosa using polymerase chain reaction am
277 osa, a distinct nonlethal form of junctional epidermolysis bullosa, using polymerase chain reaction a
278 layed the milder generalized atrophic benign epidermolysis bullosa variant.
279 lysis bullosa and all variants of junctional epidermolysis bullosa was calculated to be one in 781 an
280 t 3 and 6 months in patients with dystrophic epidermolysis bullosa was more likely with topical admin
281 that is associated with recessive dystrophic epidermolysis bullosa, was unable to form antiparallel d
282 iously disclosed in patients with dystrophic epidermolysis bullosa, we studied how these amino acid s
283 atients with pemphigus, and 79 patients with epidermolysis bullosa were analyzed).
284 an families with generalized atrophic benign epidermolysis bullosa who share the same COL17A1 mutatio
285 riasis, infantile hemangiomas and dystrophic epidermolysis bullosa will be discussed.
286 EB (OMIM# 226650), is a nonlethal variant of epidermolysis bullosa with autosomal recessive inheritan
287 monstrated in patients with a lethal form of epidermolysis bullosa with congenital pyloric atresia (O
288 me ITGB4 mutations in nonlethal phenotype of epidermolysis bullosa with congenital pyloric atresia.
289                                   Junctional epidermolysis bullosa with congenital pyloric or duodena
290  seven children who had recessive dystrophic epidermolysis bullosa with immunomyeloablative chemother
291       The human autosomal recessive disorder epidermolysis bullosa with muscular dystrophy (MD-EBS) s
292                                In junctional epidermolysis bullosa with pyloric atresia (alpha6beta4
293                                              Epidermolysis bullosa with pyloric atresia (EB-PA), an a
294                                              Epidermolysis bullosa with pyloric atresia (EB-PA), mani
295                                              Epidermolysis bullosa with pyloric atresia (EB-PA; OMIM
296     Immunofluorescence studies of junctional epidermolysis bullosa with pyloric atresia (JEB-PA) have
297 rome resembling the human disease junctional epidermolysis bullosa with pyloric atresia (PA-JEB).
298 e report a patient with a form of junctional epidermolysis bullosa with skin fragility and dental ano
299 ave been published in the field of inherited epidermolysis bullosa within the past few years.
300 13 patients with severe recessive dystrophic epidermolysis bullosa yielding a detection sensitivity o

 
Page Top